Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 15, Status: Authorised

Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Date of authorisation: 21/03/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Simbrinza, brinzolamide,brimonidine tartrate, Date of authorisation: 18/07/2014, Revision: 12, Status: Authorised

Appendix 1: Acceptable intakes established for N-nitrosamines

Human medicines European public assessment report (EPAR): Ebilfumin, oseltamivir, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 38, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Syvazul BTV, bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3), Status: Authorised